United Therapeutics Corporation Earnings

The next earnings date for United Therapeutics Corporation is July 29, 2025.

They are scheduled to announce earnings before the market opens that day.

Analyst Estimates of United Therapeutics Corporation Earnings

Report DateEstimated Earnings Per Share
10/29/2025$7.61
07/29/2025$7.35

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

United Therapeutics Corporation Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
04/29/2025Before Market$6.63-0.46%
02/19/2025Before Market$6.19-1.23%
10/30/2024Before Market$6.39-0.62%
07/31/2024Before Market$5.85-8.59%
05/01/2024Before Market$6.179.20%
02/21/2024Before Market$4.364.06%
11/01/2023Before Market$5.386.75%
08/02/2023Before Market$5.2416.19%
05/03/2023Before Market$4.867.52%
02/22/2023Before Market$2.67-40.80%
11/02/2022Before Market$4.9126.22%
08/03/2022Before Market$2.41-41.65%
05/04/2022Before Market$5.0350.15%
02/24/2022Before Market$2.35-36.83%
11/03/2021Before Market$3.42-4.74%
08/04/2021Before Market$3.6520.86%
05/05/2021Before Market$0.61-79.25%
02/24/2021Before Market$2.19-30.25%
10/28/2020Before Market$3.8636.40%
07/29/2020Before Market$2.41-16.03%
04/29/2020Before Market$3.1213.45%
02/26/2020Before Market$1.20-55.22%
10/30/2019Before Market$3.1629.51%
07/31/2019Before Market$4.1165.06%
05/01/2019Before Market$2.811.08%
02/27/2019Before Market$1.48-41.96%
10/31/2018Before Market$2.42-25.54%
08/01/2018Before Market$3.9825.55%
05/02/2018Before Market$5.5758.24%
02/21/2018Before Market$3.890.00%
10/25/2017Before Market$6.2762.02%
07/27/2017Before Market$4.4021.88%
04/26/2017Before Market$3.8917.52%
02/22/2017Before Market$2.49-31.02%
10/27/2016Before Market$3.504.79%
07/28/2016Before Market$4.3936.34%
04/28/2016Before Market$4.8450.78%
02/25/2016Before Market$2.10-17.65%
10/27/2015Before Market$4.9193.31%
07/28/2015Before Market$1.91-17.32%
04/28/2015Before Market$-0.36-116.82%
02/24/2015Before Market$2.3716.75%
10/28/2014Before Market$-0.53-126.90%
07/29/2014---$2.1020.00%
04/29/2014---$2.4347.27%
02/25/2014---$-0.60-139.74%
10/29/2013---$1.17-26.42%
07/25/2013---$1.523.40%
04/25/2013---$1.19-19.05%
02/26/2013---$1.6028.00%
11/01/2012---$1.04-17.46%
07/26/2012---$1.3419.64%
04/26/2012---$1.2938.71%
02/14/2012---$0.77-11.49%
10/27/2011---$1.3280.82%
07/28/2011---$1.18122.64%
04/28/2011---$0.26-59.38%
02/15/2011---$0.15-75.81%
10/28/2010---$0.6622.22%
07/28/2010---$0.6237.78%
04/29/2010---$0.3210.34%
02/16/2010---$-0.06-121.43%
10/29/2009---$0.21-30.00%
07/31/2009---$-0.04-114.81%
05/01/2009---$0.25-19.35%
02/17/2009---$-1.71-757.69%
10/30/2008---$0.25-13.79%
07/31/2008---$0.303.45%
05/01/2008---$0.24-11.11%
02/19/2008---$0.04-81.82%
11/01/2007---$0.3394.12%
07/31/2007---$0.13-27.78%
05/01/2007---$0.22-26.67%
02/20/2007---$0.388.57%
10/31/2006---$0.3742.31%
08/01/2006---$0.3470.00%
05/02/2006---$0.20-16.67%
02/21/2006---$0.5772.73%
10/31/2005---$0.3129.17%
08/02/2005---$0.2556.25%
05/03/2005---$0.1614.29%
02/22/2005---$0.1440.00%
11/03/2004---$0.1475.00%
08/03/2004---$0.09---
05/06/2004---$-0.04-300.00%
02/24/2004---$-0.07-75.00%
11/06/2003---$-0.0325.00%
08/05/2003---$-0.050.00%
05/06/2003---$-0.0722.22%
02/25/2003---$-0.0625.00%
11/08/2002---$-0.1412.50%
06/30/2002---$-0.08---
03/31/2002---$-0.14---
12/31/2001---$-0.18---
09/30/2001---$-0.24---
08/10/2001---$-0.26-8.33%
05/09/2001---$-0.230.00%
03/21/2001---$-0.29-16.00%
11/02/2000---$-0.1737.04%
08/09/2000---$-0.240.00%
05/09/2000---$-0.224.35%
03/02/2000---$-0.280.00%
11/08/1999---$-0.2023.08%
06/30/1999---$-0.27---

More About United Therapeutics Corporation

Website
https://www.unither.com
Country
USA
Full Time Employees
1,305

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, the company involved in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. United Therapeutics Corporation was incorporated in 1996 and is headquartered in Silver Spring, Maryland.

“United Therapeutics Corporation Earnings” Can Refer to the United Therapeutics Corporation Earnings Date

Some people say “United Therapeutics Corporation earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my United Therapeutics Corporation position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning United Therapeutics Corporation Stock on the Earnings Date

If you own United Therapeutics Corporation stock (UTHR) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for United Therapeutics Corporation might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading United Therapeutics Corporation shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More United Therapeutics Corporation Earnings

You can contact us any time if you would like to ask questions about United Therapeutics Corporation earnings or anything else related to the stock market.